HOME >> MEDICINE >> NEWS
Popular anti-epileptic drug also effective in controlling debilitating symptom of multiple sclerosis

A study published in the December issue of Archives of Neurology and currently available online shows that levetiracetam reduced phasic spasticity, which is marked by spasms and painful muscle cramps, in 100 percent of patients in a small clinical study.

"It's amazing how many MS patients can't walk, can't move, and you treat their spasticity and they're fine," said Dr. Kathleen Hawker, assistant professor of neurology at UT Southwestern and lead author of the study. "What's nice about these drugs is that they also work for nerve pain, which in turn improves the patient's mood, so we can use one drug for three things instead of prescribing pain killers and antidepressants in addition to the spasticity therapies."

Spasticity is often seen in patients with MS and amyotrophic lateral sclerosis (ALS), as well as after a stroke or spinal-cord injury. It can lead to loss of balance, increased risk of falls, pain, fatigue, and walking difficulties.

Drugs currently used to treat spasticity may cause memory problems, weakness and lethargy in some patients.

"We're trying to look at medicines that can be used for multiple symptoms so we don't get into a lot of drug interactions," Dr. Hawker said. "If we can get the same results with a better-tolerated drug, that's great for our patients."

Researchers examined the histories of 11 patients treated with levetiracetam between January 2001 and June 2002 for MS-related spasticity at Southwestern Medical Center. The patients were treated with levetiracetam for one to four months, with dosages starting at 250 milligrams per day and increasing to 3,000 mg per day. Researchers found that leviteracetam decreased phasic spasticity in patients taking the drug alone as well as in those who took it in combination with other therapies for spasticity. Tonic spasticity, which produces stiffness, did not improve. Overall, the clinical investigators found the side effects of levetiracetam to be gener
'"/>

Contact: Rachel Horton
rachel.horton@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
15-Dec-2003


Page: 1 2

Related medicine news :

1. Popular chewing gum eliminates bacteria that cause bad breath
2. Popular drug for chest pain may promote blood vessel damage
3. Popular long-acting contraceptive linked to vascular dysfunction
4. Popular asthma drug inadequate when used alone, new study shows
5. Popular herbal remedy fails effectiveness test for tinnitus
6. Popular notions about breast cancer-psychology link challenged
7. Sexually Oriented Internet Sites Are Popular And Non-Problematic For Most People, But Pose Risks For Some
8. UCSF Study Finds Popular Blood Thinner Does Not Weaken Bones
9. Survey Finds Increasing Popularity Of Acute Stroke Teams In U.S. Hospitals
10. Strategy effective against drug resistant tuberculosis
11. Study shows patch therapy may be as effective as oral medications

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/15/2019)... ... May 16, 2019 , ... Statistical Concepts of Process ... 3:00 p.m. EDT, https://www.fdanews.com/statisticalconceptsprocessvalidation , Devicemakers: Are the organizations process validation ... maybe … Dan O’Leary is here to help. Dan is FDAnews’s go-to guy ...
(Date:5/14/2019)... ... ... at 7pm for the Healthy Woman Show on WJR 760AM radio hosted by Women’s Excellence. ... and inconvenient for women. , “We know how bladder control problems can affect your ... home. Our goal is to help you stop leaking so that you can live ...
(Date:5/14/2019)... ... 2019 , ... The Atlanta Falcons, the Baltimore Ravens and ... the U.S. who rely on HydroWorx aquatic therapy pools to care for their ... healing,” said Timothy McCarthy, Chief Executive Officer for HydroWorx. “Whether it’s for ...
(Date:5/14/2019)... ... May 14, 2019 , ... The Medicus Firm, (TMF) ... Healthcare as one of the nation's Best Places to Work in Healthcare 2019. This is ... comes on the heels of being named among Forbes’ Best Professional Recruiting Firms ...
(Date:5/14/2019)... (PRWEB) , ... May 14, 2019 , ... Dr. Roger ... a minimally invasive gum disease treatment option for patients. Dr. Chan is among a ... still has excellent results. , "Gum disease is an insidious disease because there aren't ...
Breaking Medicine News(10 mins):
(Date:5/16/2019)... ... May 16, 2019 , ... Actuate Therapeutics, Inc., a clinical stage biopharmaceutical ... The Series B is led by Kairos Ventures, with DEFTA Partners, Tech Coast ... the financing to expand the company’s ongoing Phase 1 / 2 clinical trial and ...
(Date:5/16/2019)... ... May 16, 2019 , ... Guruji ... today’s issues affecting humanity at practical and spiritual levels. , Founder of ... connection to the God of their understanding, as well as, to illuminate the ...
(Date:5/16/2019)... ... May 16, 2019 , ... Luma Health ... launched Mobile Patient Intake. This new solution helps providers deliver a top-notch patient ... own convenience, on their device of choice, days or weeks prior to their ...
Breaking Medicine Technology:
Cached News: